Johnson & Johnson (JNJ) Declares $1.30 Quarterly Dividend; 3.4% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- CoreWeave stock drops on dilution fears and debt concerns
- SpaceX to acquire Grain Management's 800 MHz spectrum portfolio
- Oracle and these 6 stocks are newest addition to Mizuho Top Picks list
- Anthropic launches cyber defense program for infrastructure and open-source
- Devon Energy to sell Eagle Ford assets to Crescent Energy for $4.2B
Johnson & Johnson (JNJ) PT Raised to $185 at Goldman Sachs
July 17, 2025 6:07 AM EDTGoldman Sachs analyst Asad Haider raised the price target on Johnson & Johnson (NYSE: JNJ) to $185.00 (from $177.00) while maintaining a Buy rating.
The analyst comments "In a backdrop where we had that noted our investor conversations suggest sentiment shifting slightly more positive on the tactical setup for US pharma into 2Q earnings season (see: link), JNJ shares... More



